AGS-67E

N/A

Report date: 2024/02/05 13:52:41

Base Information

Drug NameAGS-67E
Drug Alias NameAGS-67E
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker > VC linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > MMAE payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionTubulin polymerisation inhibitorsLeukocyte antigen CD37 antagonists
TargetsLeukocyte antigen CD37Tubulin
Therapy Area/IndicationsLymphoma, Non-HodgkinLeukemia, Myeloid, AcuteLeukemia, Lymphocytic, Chronic, B-Cell +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAgensys Inc
China Registration ClassN/A

Develop Information

Active CompaniesAgensys Inc
Inactive CompaniesN/A
Active IndicationsLymphoma, Non-HodgkinLeukemia, Myeloid, AcuteLeukemia, Lymphocytic, Chronic, B-Cell +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A